ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ADCT ADC Therapeutics SA

4,65
0,45 (10,71%)
29 Mär 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ADC Therapeutics SA ADCT NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,45 10,71% 4,65 00:19:36
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,36 4,3421 5,01 4,49 4,20
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.3.202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13.3.202412:00GLOBEADC Therapeutics Reports Fourth Quarter and Full Year 2023..
06.3.202413:15GLOBEADC Therapeutics to Participate in the Guggenheim 5th Annual..
06.3.202413:00GLOBEADC Therapeutics to Host Fourth Quarter and Year-End 2023..
05.3.202423:45GLOBEADC Therapeutics Announces Abstracts Accepted for..
05.3.202415:15EDGAR2Form 8-K - Current report
29.2.202422:30EDGAR2Form 8-K - Current report
27.2.202413:00GLOBEADC Therapeutics to Participate in the TD Cowen 44th Annual..
24.1.202414:00EDGAR2Form 8-K - Current report
19.1.202422:30EDGAR2Form 8-K - Current report
04.1.202413:15EDGAR2Form 8-K - Current report
04.1.202413:15GLOBEADC Therapeutics Regains Compliance with NYSE Continued..
04.1.202413:00EDGAR2Form 8-K - Current report
04.1.202413:00GLOBEADC Therapeutics Provides Business Updates
03.1.202402:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202402:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202402:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202401:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202401:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
19.12.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18.12.202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
12.12.202311:15GLOBEADC Therapeutics Announces Initial Results from..
04.12.202322:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
20.11.202308:40PRNUSSobi to present new data at ASH 2023 Annual Meeting
15.11.202309:00GLOBEMyricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur..
07.11.202313:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.11.202313:15GLOBEADC Therapeutics Receives NYSE Notice of Non-Compliance With..
07.11.202313:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.11.202313:00GLOBEADC Therapeutics Reports Third Quarter 2023 Financial..
06.11.202313:00GLOBEADC Therapeutics to Participate in the Jefferies London..
02.11.202315:10GLOBEADC Therapeutics Announces Abstracts Accepted for..
24.10.202313:00GLOBEADC Therapeutics to Host Third Quarter 2023 Financial..
04.10.202310:00GLOBEMyricx Expands its ADC Expertise with the Appointment of..
11.9.202313:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.9.202313:00GLOBEADC Therapeutics to Participate in September Investor..
31.8.202301:32GLOBEADC Therapeutics Announces Updates on ZYNLONTA® LOTIS..
08.8.202313:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.8.202313:00GLOBEADC Therapeutics Reports Second Quarter 2023 Financial..
01.8.202313:00GLOBEADC Therapeutics to Host Second Quarter 2023 Financial..
24.7.202313:21GLOBEOverland ADCT BioPharma Announces NMPA Accepts Biologics..
20.7.202322:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.7.202322:05GLOBEADC Therapeutics Announces Plan to Discontinue the Phase 2..
11.7.202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.7.202313:00GLOBEADC Therapeutics Announces Voluntary Pause of Enrollment in..
15.6.202313:15GLOBEADC Therapeutics Announces Evolution of Board of Directors
09.6.202313:15GLOBEADC Therapeutics Announces Updated LOTIS-2 Results..
01.6.202313:15GLOBEADC Therapeutics to Participate in the Jefferies Healthcare..
12.5.202300:36BWADC Therapeutics annonce que les derniers résultats de son..
11.5.202323:46BWADC Therapeutics gibt aktualisierte Ergebnisse der..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock